PL2626420T3 - Polinukleotydy kodujące epitopy hTERT ograniczone do MHC klasy I HLA-B7, ich analogi lub poliepitopy - Google Patents
Polinukleotydy kodujące epitopy hTERT ograniczone do MHC klasy I HLA-B7, ich analogi lub poliepitopyInfo
- Publication number
- PL2626420T3 PL2626420T3 PL13165854T PL13165854T PL2626420T3 PL 2626420 T3 PL2626420 T3 PL 2626420T3 PL 13165854 T PL13165854 T PL 13165854T PL 13165854 T PL13165854 T PL 13165854T PL 2626420 T3 PL2626420 T3 PL 2626420T3
- Authority
- PL
- Poland
- Prior art keywords
- polyepitopes
- hla
- analogues
- mhc class
- polynucleotides encoding
- Prior art date
Links
- 102000043129 MHC class I family Human genes 0.000 title 1
- 108091054437 MHC class I family Proteins 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05291627A EP1748067A1 (en) | 2005-07-29 | 2005-07-29 | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2626420T3 true PL2626420T3 (pl) | 2017-01-31 |
Family
ID=35735256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13165854T PL2626420T3 (pl) | 2005-07-29 | 2006-07-31 | Polinukleotydy kodujące epitopy hTERT ograniczone do MHC klasy I HLA-B7, ich analogi lub poliepitopy |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8858931B2 (pl) |
| EP (3) | EP1748067A1 (pl) |
| JP (4) | JP5631545B2 (pl) |
| CA (1) | CA2616674C (pl) |
| DK (2) | DK1910529T3 (pl) |
| ES (2) | ES2590462T3 (pl) |
| PL (1) | PL2626420T3 (pl) |
| PT (1) | PT2626420T (pl) |
| WO (1) | WO2007014740A2 (pl) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10767167B2 (en) | 2005-07-29 | 2020-09-08 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| EP1748067A1 (en) * | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| WO2008010010A1 (en) * | 2006-07-12 | 2008-01-24 | Vaxon Biotech | Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| US20080171062A1 (en) * | 2006-08-16 | 2008-07-17 | Monica Sala-Schaeffer | Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use |
| WO2008106551A2 (en) * | 2007-02-28 | 2008-09-04 | The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. | Brachyury polypeptides and methods for use |
| BRPI0813626A2 (pt) * | 2007-07-27 | 2014-12-23 | Immatics Biotechnologies Gmbh | Epitopos imunogênicos para a imunoterapia |
| US7904566B2 (en) * | 2008-03-14 | 2011-03-08 | Silicon Image, Inc. | Method, apparatus, and system for employing an enhanced port multiplier |
| US7979589B2 (en) * | 2008-03-14 | 2011-07-12 | Silicon Image, Inc. | Method, apparatus, and system for port multiplier enhancement |
| EP3581649A1 (en) | 2010-02-16 | 2019-12-18 | Ultimovacs ASA | Polypeptides |
| RU2014140792A (ru) | 2012-03-15 | 2016-05-10 | Макрокьюэ, Лтд. | Активированная иммуностимулирующая клеточная композиция и ее использование |
| CA2864838A1 (en) | 2012-03-15 | 2013-09-19 | Macrocure, Ltd. | Activated immunostimulatory cell composition for therapy of infection |
| EP2639299A1 (en) | 2012-03-16 | 2013-09-18 | Invectys | Universal cancer peptides derived from telomerase |
| KR102201429B1 (ko) * | 2012-09-19 | 2021-01-12 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
| WO2014105870A1 (en) * | 2012-12-27 | 2014-07-03 | Sierra Sciences, Inc. | Enhancing health in mammals using telomerase reverse transcriptase gene therapy |
| WO2014154905A1 (en) * | 2013-03-28 | 2014-10-02 | Invectys | A cancer vaccine for dogs |
| WO2014154904A1 (en) | 2013-03-28 | 2014-10-02 | Invectys | A cancer vaccine for cats |
| GB201315946D0 (en) * | 2013-09-06 | 2013-10-23 | Immune Targeting Systems Its Ltd | Oncology vaccine |
| US10183065B2 (en) * | 2013-10-28 | 2019-01-22 | Invectys | Telomerase encoding DNA vaccine |
| DK3063280T3 (da) | 2013-10-28 | 2019-11-11 | Invectys | Genelektrooverførsel ind i hudceller |
| CA2973978A1 (en) | 2015-01-14 | 2016-07-21 | The Brigham And Women's Hospital, Inc. | Treatment of cancer with anti-lap monoclonal antibodies |
| US11254914B2 (en) | 2015-03-12 | 2022-02-22 | Health Research, Inc. | Enrichment of CD16+ monocytes to improve dendritic cell vaccine quality |
| WO2016168601A1 (en) | 2015-04-17 | 2016-10-20 | Khalid Shah | Agents, systems and methods for treating cancer |
| EP3359183B1 (en) * | 2015-10-06 | 2020-06-17 | Invectys | Polyepitope constructs for use in immunotherapy |
| GB201519557D0 (en) | 2015-11-05 | 2015-12-23 | Univ Witwatersrand Jhb | Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions |
| ES2811523T3 (es) | 2016-01-19 | 2021-03-12 | Pfizer | Vacunas contra el cáncer |
| WO2018064588A2 (en) | 2016-09-30 | 2018-04-05 | Weiner, David | Tert immunogenic compositions and methods of treatment using the same |
| WO2018206512A1 (en) | 2017-05-09 | 2018-11-15 | Invectys | Recombinant measles vaccine expressing htert |
| TWI837109B (zh) * | 2017-12-28 | 2024-04-01 | 美商磨石生物公司 | 靶向共有抗原之抗原結合蛋白 |
| CN110305217B (zh) | 2018-03-27 | 2022-03-29 | 广州爱思迈生物医药科技有限公司 | 双特异性抗体及其应用 |
| WO2019197610A1 (en) | 2018-04-13 | 2019-10-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New vaccinal strategy |
| US11702450B2 (en) * | 2018-08-30 | 2023-07-18 | Université de Montréal | Proteogenomic-based method for identifying tumor-specific antigens |
| CN113105528B (zh) * | 2020-01-13 | 2023-12-08 | 辽宁中健医药科技有限公司 | 一条肿瘤相关抗原ctl表位肽及其应用 |
| EP4171619A4 (en) * | 2020-06-26 | 2024-08-07 | National Breast Cancer Coalition | BREAST CANCER VACCINE |
| CN118792176A (zh) * | 2024-07-24 | 2024-10-18 | 佳吾益(北京)科技有限公司 | 用于mhc新抗原肽发现及亲和分析的工程化细胞 |
| WO2026020513A1 (en) * | 2024-07-24 | 2026-01-29 | Jwe (Beijing) Science Technology, Inc. | Engineered cell for identifing mhc neoantigens |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1254376A (zh) * | 1996-10-01 | 2000-05-24 | 杰龙公司 | 端粒酶逆转录酶 |
| US7622549B2 (en) * | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
| US7413864B2 (en) * | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
| CN1270634A (zh) * | 1997-07-01 | 2000-10-18 | 卡姆比亚生物系统有限责任公司 | 脊椎动物端粒酶基因和蛋白质及其用途 |
| WO1999050392A1 (en) * | 1998-03-31 | 1999-10-07 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| EP2169073B1 (en) | 1999-10-11 | 2013-11-13 | Institut Pasteur | Vector for the preparation of immunotherapeutical compositions |
| WO2001027304A2 (en) | 1999-10-12 | 2001-04-19 | Institut Pasteur | Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| FR2862648B1 (fr) * | 2003-11-21 | 2006-02-03 | Biomerieux Sa | Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c |
| CA2504451A1 (en) * | 2004-08-10 | 2006-02-10 | Geron Corporation | Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| EP1748067A1 (en) | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
-
2005
- 2005-07-29 EP EP05291627A patent/EP1748067A1/en not_active Ceased
-
2006
- 2006-07-31 DK DK06762910.5T patent/DK1910529T3/da active
- 2006-07-31 EP EP06762910.5A patent/EP1910529B1/en active Active
- 2006-07-31 CA CA2616674A patent/CA2616674C/en active Active
- 2006-07-31 EP EP13165854.4A patent/EP2626420B1/en active Active
- 2006-07-31 DK DK13165854.4T patent/DK2626420T3/en active
- 2006-07-31 ES ES13165854.4T patent/ES2590462T3/es active Active
- 2006-07-31 JP JP2008523267A patent/JP5631545B2/ja not_active Expired - Fee Related
- 2006-07-31 ES ES06762910.5T patent/ES2440768T3/es active Active
- 2006-07-31 WO PCT/EP2006/007571 patent/WO2007014740A2/en not_active Ceased
- 2006-07-31 US US11/795,027 patent/US8858931B2/en active Active
- 2006-07-31 PL PL13165854T patent/PL2626420T3/pl unknown
- 2006-07-31 PT PT131658544T patent/PT2626420T/pt unknown
-
2007
- 2007-07-12 US US11/826,134 patent/US8003773B2/en active Active
-
2012
- 2012-06-13 JP JP2012133834A patent/JP5836202B2/ja active Active
-
2013
- 2013-08-09 JP JP2013166103A patent/JP5931812B2/ja active Active
- 2013-08-26 US US13/975,404 patent/US9624479B2/en active Active
-
2016
- 2016-02-19 JP JP2016029927A patent/JP6257667B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2626420A3 (en) | 2013-10-30 |
| WO2007014740A3 (en) | 2007-05-03 |
| JP2009502150A (ja) | 2009-01-29 |
| EP2626420B1 (en) | 2016-06-22 |
| US20100172878A1 (en) | 2010-07-08 |
| US9624479B2 (en) | 2017-04-18 |
| US20090175892A1 (en) | 2009-07-09 |
| DK1910529T3 (da) | 2014-01-13 |
| EP2626420A2 (en) | 2013-08-14 |
| DK2626420T3 (en) | 2016-09-26 |
| US8003773B2 (en) | 2011-08-23 |
| US20140056932A1 (en) | 2014-02-27 |
| EP1910529A2 (en) | 2008-04-16 |
| CA2616674C (en) | 2018-09-04 |
| EP1748067A1 (en) | 2007-01-31 |
| CA2616674A1 (en) | 2007-02-08 |
| ES2440768T3 (es) | 2014-01-30 |
| EP1910529B1 (en) | 2013-10-16 |
| JP2016104031A (ja) | 2016-06-09 |
| PT2626420T (pt) | 2016-09-28 |
| JP5931812B2 (ja) | 2016-06-08 |
| WO2007014740A2 (en) | 2007-02-08 |
| ES2590462T3 (es) | 2016-11-22 |
| JP2013230164A (ja) | 2013-11-14 |
| JP5631545B2 (ja) | 2014-11-26 |
| JP5836202B2 (ja) | 2015-12-24 |
| US8858931B2 (en) | 2014-10-14 |
| JP6257667B2 (ja) | 2018-01-10 |
| JP2012183076A (ja) | 2012-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2626420T (pt) | Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos | |
| EG25263A (en) | Fungicidal mixtures based on azolopyrimidinylamines. | |
| DK1849470T4 (en) | Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor | |
| EG25271A (en) | Fungicidal combinations. | |
| EG25126A (en) | Steam reforming. | |
| IL209963A0 (en) | Epitope analogues | |
| PT2878307T (pt) | Composição imunogénica. | |
| EP1910920A4 (en) | CODE TRANSFORMATION | |
| EG25121A (en) | Steam reforming. | |
| AP2281A (en) | Novel compounds. | |
| PT2468732E (pt) | 1h-quinazolino-2,4-dionas e sua utilização como ligandos dos receptores ampa | |
| EP1841430A4 (en) | SUBSTITUTED PYRIDAZINYL AND PYRIMIDINYL-CHINOLIN-4-YLAMINE ANALOGUE | |
| SI2221383T1 (sl) | Nukleotidna sekvenca, ki kodira proti-glivični polipeptid | |
| IL190538A0 (en) | Two-part code | |
| AP2337A (en) | Motilide compounds. | |
| EP1874979A4 (en) | REACTOR | |
| EP1723145A4 (en) | SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA | |
| IL185408A0 (en) | (+)-and(-)-8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1)oct-2-ene | |
| GB0516252D0 (en) | The dive daemon | |
| GB0507105D0 (en) | Coding data | |
| GB0504761D0 (en) | Alfatie, Coliawel, Omaatie | |
| AU4212P (en) | Goldenlighthouse Banksia spinulosa var. collina | |
| GB0500851D0 (en) | C.f.m. | |
| ZA200407886B (en) | Locking arrangement. | |
| GB0506690D0 (en) | Authentication system |